Volume 90 Issue 36 | p. 29 | Concentrates
Issue Date: September 3, 2012

Former Roche Exec To Lead AstraZeneca

Department: Business
Keywords: pharmaceuticals, management, diagnostics
[+]Enlarge
Soriot
Credit: AstraZeneca
Photo of Pascal Soriot.
 
Soriot
Credit: AstraZeneca

Pascal Soriot, former head of Roche’s pharmaceutical division, has been named AstraZeneca’s new CEO. He will join AstraZeneca on Oct. 1, and interim CEO Simon Lowth will return to his role as chief financial officer. Prior to starting his now 26-year career in the drug industry, Soriot, 53, was a practicing veterinarian. Meanwhile, effective Sept. 1, Daniel O’Day will lead Roche Pharma and Roland Diggelmann will succeed him as head of Roche Diagnostics.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment